Jacinthe Guindon

Jacinthe Guindon has more than 30 years of experience in all facets of clinical development that span pharmaceuticals, biopharmaceuticals and medical devices in both the United States and Canada. Jacinthe has been responsible for the strategic planning and management of clinical trials, focusing primarily on the clinical project life cycle and regulatory issues, and supporting M&A activities. She brings strong client and project management and a can-do attitude to all her projects.

Throughout her experience in the industry, Jacinthe has held various roles, from Clinical Monitor to Director, prior to entering the consulting services arena in 2018 and joining FTI Consulting in 2022 as a leader for the Health Solutions Life Sciences Research and Development division.

Jacinthe has managed Clinical and Scientific Advisory Boards, Safety Monitoring Committees and has been a key member of M&A teams and meetings with the Food and Drug Administration (“FDA”), as well as Health Canada and Health Europe, Middle East and Africa (EMEA). She has extensive experience with Contract Research Organization (“CRO”) management resulting in cost savings and timeline reduction.

In Jacinthe’s tenure at various pharma and biotech companies, she has overseen the development of many therapeutics, from early-stage first-in-human to approval, in both the United States and Canada.